Arterra Bioscience Logo

Arterra Bioscience

ABS | XMIL

Overview

Corporate Details

ISIN(s):
IT0005386369
LEI:
8156006E67B9AB95E292
Country:
Italy
Address:
VIA BENEDETTO BRIN, 69, 80142 NAPOLI
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Arterra Bioscience is a biotech company listed on the “Euronext Growth Milan” market of Borsa Italiana since 2019, founded in Naples by M. Gabriella Colucci in 2004 with the aim of developing technologies and innovative solutions that find application in various industrial sectors. Arterra is a company strongly linked to the Campania region from which it derives the natural raw materials underlying many of its actives, as well as being able to take advantage of the ideas and enthusiasm of its young researchers.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-01 17:59
M&A Activity
ARTERRA BIOSCIENCE S.P.A. HA CEDUTO L’INTERA PARTECIPAZIONE DETENUTA NEL CAPITA…
Italian 245.2 KB
2025-07-31 16:27
Regulatory News Service
ARTERRA BIOSCIENCE S.P.A. HA CEDUTO L’INTERA PARTECIPAZIONE DETENUTA NEL CAPITA…
Italian 244.9 KB
2025-07-18 13:28
Earnings Release
ARTERRA BIOSCIENCE S.P.A.: FATTURATO AL 30 GIUGNO 2025 PARI A CIRCA 2,6 MILIONI…
Italian 256.6 KB
2025-06-23 17:43
Director's Dealing
Arterra - Allegato A (Manager) - Notifica di comunicazione
Italian 133.7 KB
2025-06-23 17:36
Major Shareholding Notification
ARTERRA - CAMBIAMENTO SOSTANZIALE IN MATERIA DI ASSETTI PROPRIETARI
Italian 254.7 KB
2025-06-12 21:25
Report Publication Announcement
ARTERRA BIOSCIENCE S.P.A. PARTECIPA ALL’EVENTO “FINANCIAL GALÀ” ORGANIZZATO DA …
Italian 350.6 KB
2025-05-19 19:14
Capital/Financing Update
ARTERRA - FINANZIAMENTO E CONCESSIONE AGEVOLAZIONI PER IL PROGETTO “SmartLAB 2.…
Italian 319.2 KB
2025-05-06 11:21
Earnings Release
ARTERRA - FATTURATO AL 31 MARZO 2025 PARI A CIRCA 1,3 MILIONI DI EURO
Italian 253.5 KB
2025-04-29 13:44
Post-Annual General Meeting Information
ARTERRA BIOSCIENCE - ASSEMBLEA ORDINARIA DEGLI AZIONISTI
Italian 347.4 KB
2025-04-23 18:40
Pre-Annual General Meeting Information
ARTERRA - DEPOSITO E PUBBLICAZIONE DELLE LISTE PER LA NOMINA DEI MEMBRI DEL CON…
Italian 302.5 KB
2025-04-03 19:19
Pre-Annual General Meeting Information
ARTERRA - PUBBLICAZIONE AVVISO DI CONVOCAZIONE DI ASSEMBLEA ORDINARIA
Italian 340.4 KB
2025-03-28 11:49
Earnings Release
Arterra - Il Consiglio di Amministrazione ha approvato il progetto di Bilancio …
Italian 297.4 KB
2025-02-13 12:35
Earnings Release
ARTERRA BIOSCIENCE S.P.A.: FATTURATO AL 31 DICEMBRE 2024 PARI A 4,2 MILIONI DI …
Italian 248.2 KB
2024-11-04 11:58
Earnings Release
ARTERRA - FATTURATO AL 30 SETTEMBRE 2024 PARI A CIRCA 2.8 MILIONI DI EURO
Italian 248.4 KB
2024-10-02 18:30
Environmental & Social Information
ARTERRA - CONCESSIONE AGEVOLAZIONI
Italian 238.1 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Can-Fite BioPharma Ltd. Logo Can-Fite BioPharma Ltd. Israel CANF
Cantargia Logo Cantargia Sweden CANTA
Captor Therapeutics S.A. Logo Captor Therapeutics S.A. Poland CTX
Carbiotix AB Logo Carbiotix AB Sweden CRBX
Cellectis Logo Cellectis France ALCLS
CELLULAR GOODS PLC Logo CELLULAR GOODS PLC United Kingdom CBX
Celyad Oncology SA Logo Celyad Oncology SA Belgium CYAD
Cereno Scientific AB Logo Cereno Scientific AB Sweden CRNO
Cessatech A/S Logo Cessatech A/S Denmark CESSA
CHOSA Oncology AB Logo CHOSA Oncology AB Sweden CHOSA